Chinese General Practice ›› 2018, Vol. 21 ›› Issue (29): 3562-3570.DOI: 10.3969/j.issn.1007-9572.2018.00.249
• Monographic Research • Previous Articles Next Articles
Published:
2018-10-15
Online:
2018-10-15
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.3969/j.issn.1007-9572.2018.00.249
[1]陈灏珠,钟南山,陆再英,等.动脉粥样硬化和冠状动脉粥样硬化性心脏病[M]//葛均波,徐永健.内科学(8版).北京:人民卫生出版社,2013:220-256.3568 CHEN H Z,ZHONG N S,LU Z Y,et al.Atherosclerosis and coronary atherosclerotic heart disease[M]//GE J B,XU Y J.Internal medicine(8th edtion).Beijing:People's Medical Publishing House,2013:220-256.3568 [2]卫生部心血管病防治研究中心.中国心血管病报告[J].北京:中国大百科全书出版社,2012.3568 Ministry of Public Health Cardiovascular Prevention Research Center.Reports on cardiovascular diseases in China[J].Beijing:Encyclopedia of China Publishing House,2012.3568 [3]XU Y,WANG L,HE J,et al.Prevalence and control of diabetes in Chinese adults[J].JAMA,2013,310(9):948-959.DOI:10.1001/jama.2013.168118.3568 [4]ROGER V L,GO A S,LLOYD-JONES D M,et al.Executive summary:heart disease and stroke statistics-2012 update:a report from the American Heart Association[J].Circulation,2012,125 (1):188-197.DOI:10.1161/CIR.0b013e31823ac046.3568 [5]冉进军,姜媛,刘巧兰,等.冠心病危险因素的Meta分析[J].西部医学,2014,26(12):1629-1632.DOI:10.3969/j.issn.1672-3511.2014.12.020.3568 RAN J J,JIANG Y,LIU Q L,et al.Meta-analysis on the risks factors of coronary heart disease[J].Medical Journal of West China,2014,26(12):1629-1632.DOI:10.3969/j.issn.1672-3511.2014.12.020.3568 [6]MATSUSHITA K,CORESH J,SANG Y,et al.Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes a collaborative meta-analysis of individual participant data[J].Lancet Diabetes Endocrinol,2015,3(7):514-525.DOI:10.1016/S2213-8587(15)00040-6.3568 [7]中华医学会心血管病学分会,中华心血管病杂志编辑委员会.慢性稳定性心绞痛诊断与治疗指南[J].中华心血管病杂志,2007,35(3):195-206.DOI:10.3760/j.issn:0253-3758.2007.03.002.3568 Chinese Society of Cardiology,Editorial Board of Chinese Journal of Cardiology.Guideline for diagnosis and treatment of patients with chronic stable angina[J].Chinese Journal of Cardiology,2007,35(3):195-206.DOI:10.3760/j.issn:0253-3758.2007.03.002.3568 [8]高洁,耿晓雯,吕中华,等.冠状动脉多支病变的危险因素分析[J].解放军医学院学报,2016,37(5):413-416,420.DOI:10.3969/j.issn.2095-5227.2016.05.002.3568 GAO J,GENG X W,LYU Z H,et al.Risk factors of multivessel coronary disease[J].Academic Journal of Pla Postgraduate Medical School,2016,37(5):413-416,420.DOI:10.3969/j.issn.2095-5227.2016.05.002.3568 [9]沈法荣,钟诚.心肌梗死诊断标准心电图变化最新指南解读[J].心电学杂志,2010,29(2):88-91.DOI:10.3969/j.issn.1002-1094.2010.02.002.3568 SHEN F R,ZHONG C.Interpretation of the newest guidelines to the diagnostic criteria of myocardial infarction and changes of electrocardiogram[J].Journal of Electrocardiology(China),2010,29(2):88-91.DOI:10.3969/j.issn.1002-1094.2010.02.002.3568 [10]中国高血压防治指南修订委员会.中国高血压防治指南2010[J].中华心血管病杂志,2011,39(7):579-616.DOI:10.3760/cma.j.issn.0253-3758.2011.07.002.3568 The Revision Committee of Chinese Guidelines for the Management of Hypertension.2010 Chinese guidelines for the management of hypertension[J].Chinese Journal of Cardiology,2011,39(7):579-616.DOI:10.3760/cma.j.issn.0253-3758.2011.07.002.3568 [11]中华医学会糖尿病学分会.中国2型糖尿病防治指南(2013年版)[J].中华糖尿病杂志,2014,6(7):447-498.DOI:10.3760/cma.j.issn.1674-5809.2014.07.004.3568 Chinese Society of Diabetes.2013 Chinese guidelines for type 2 diabetes[J].Chinese Journal of Diabetes,2014,6(7):447-498.DOI:10.3760/cma.j.issn.1674-5809.2014.07.004.3568 [12]《中国成人血脂异常防治指南》制订联合委员会.中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419.DOI:10.3760/j.issn:0253-3758.2007.05.003.The Revision Committee of Chinese Guidelines on Prevention and Treatment of Dyslipidemia in Adults.Chinese guidelines on prevention and treatment of dyslipidemia in adults[J].Chinese Journal of Cardiology,2007,35(5):390-419.DOI:10.3760/j.issn:0253-3758.2007.05.003.3568 [13]ORGANIZATION W H.Guidelines for the conduct of tobacco-smoking surveys among health professionals:report of a WHO meeting held in Winnipeg,Canada,7-9 July 1983 in collaboration with UICC and ACS[R].Geneva:World Health Organization,1984.3569 [14]马冠生,朱丹红,胡小琪,等.中国居民饮酒行为现况[J].营养学报,2005,27(5):362-365.DOI:10.3321/j.issn:0512-7955.2005.05.003.3569 MA G S,ZHU D H,HU X Q,et al.The drinking practice of people in China[J].Acta Nutrimenta Sinica,2005,27(5):362-365.DOI:10.3321/j.issn:0512-7955.2005.05.003.3569 [15]LEVEY A S,STEVENS L A,SCHMID C H,et al.A new equation to estimate glomerular filtration rate[J].Ann Intern Med,2009,150(9):604-612.3569 [16]MORAN A E,ROTH G A,NARULA J,et al.1990—2010 global cardiovascular disease atlas[J].Glob Heart,2014,9(1):3-16.DOI:10.1016/j.gheart.2014.03.1220.3569 [17]ORHO-MELANDER M.Genetics of coronary heart disease:towards causal mechanisms,novel drug targets and more personalized prevention[J].J Intern Med,2015,278(5):433-446.DOI:10.1111/joim.12407.3569 [18]FINEGOLD J A,ASARIA P,FRANCIS D P.Mortality from ischaemic heart disease by country,region,and age:statistics from World Health Organisation and United Nations[J].Int J Cardiol,2013,168(2):934-945.DOI:10.1016/j.ijcard.2012.10.046.3569 [19]彭云珠,郭涛,郑圆圆,等.急性心肌梗死患者血脂改变及其对预后的影响分析[J].重庆医学,2012,41(16):1601-1603.DOI:10.3969/j.issn.1671-8348.2012.16.015.3569 PENG Y Z,GUO T,ZHENG Y Y,et al.Change of blood lipids in acute myocardial infarction and its influence on prognosis[J].Chongqing Medicine,2012,41(16):1601-1603.DOI:10.3969/j.issn.1671-8348.2012.16.015.3569 [20]FRITZ J,EDLINGER M,KELLEHER C,et al.Mediation analysis of the relationship between sex,cardiovascular risk factors and mortality from coronary heart disease:findings from the population-based VHM&PP cohort[J].Atherosclerosis,2015,243(1):86-92.DOI:10.1016/j.atherosclerosis.2015.08.048.3569 [21]张贵龙.难治性高血压的诊治研究进展[J].河北医药,2015,37(4):591-594.DOI:10.3969/j.issn.1002-7386.2015.04.046.3569 ZHANG G L.Research progress on refractory hypertension[J].Hebei Medical Journal,2015,37(4):591-594.DOI:10.3969/j.issn.1002-7386.2015.04.046.3569 [22]IRVIN M R,BOOTH J N 3rd,SHIMBO D,et al.Apparent treatment-resistant hypertension and risk for stroke,coronary heart disease,and all-cause mortality[J].J Am Soc Hypertens,2014,8(6):405-413.DOI:10.1016/j.jash.2014.03.003.3569 [23]贾淑杰,周芸,杨红霞,等.高血压合并冠心病患者的冠脉病变特点[J].中国循证医学杂志,2011,11(6):640-643.DOI:10.3969/j.issn.1672-2531.2011.06.008.3569 JIA S J,ZHOU Y,YANG H X,et al.Characteristics of coronary artery in patients with hypertension and coronary heart disease[J].Chinese Journal of Evidence-Based Medicine,2011,11(6):640-643.DOI:10.3969/j.issn.1672-2531.2011.06.008.3569 [24]HUANG Y L,CAI X Y,LIU C H,et al.Prehypertension and the risk of coronary heart disease in Asian and Western populations:a meta-analysis[J].J Am Heart Assoc,2015,4(2):e001519.DOI:10.1161/JAHA.114.001519.3569 [25]ZANCHETTI A,GRASSI G,MANCIA G.When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered?A critical reappraisal[J].J Hypertens,2009,27(5):923-934.DOI:10.1097/HJH.0b013e32832aa6b5.3569 [26]李艳华,赵蕾,韩金凤.TC、TG和LDL-C检测在冠状动脉粥样硬化性心脏病诊断中的价值分析[J].世界最新医学信息文摘,2013,13(34):45.DOI:10.3969/j.issn.1671-3141.2013.34.034.3569 LI Y H,ZHAO L,HAN J F.The value analysis of TC,TG,and LDL-C test in the CHD diagnosis[J].World Latest Medicine Information,2013,13(34):45.DOI:10.3969/j.issn.1671-3141.2013.34.034.3569 [27]陈伟伟,高润霖,刘力生,等.《中国心血管病报告2014》概要[J].中国循环杂志,2015,30(7):617-622.DOI:10.3969/j.issn.1000-3614.2015.07.001.3569 CHEN W W,GAO R L,LIU L S,et al.2014 reports on cardiovascular diseases in China[J].Chinese Circulation Journal,2015,30(7):617-622.DOI:10.3969/j.issn.1000-3614.2015.07.001.3569 [28]STONE N J,ROBINSON J G,LICHTENSTEIN A H,et al.2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines[J].J Am Coll Cardiol,2014,63(25 Pt B):2889-2934.DOI:10.1016/j.jacc.2013.11.002.3569 [29]HONG Y J,JEONG M H,CHOI Y H,et al.Plaque characteristics in culprit lesions and inflammatory status in diabetic acute coronary syndrome patients[J].JACC Cardiovasc Imaging,2009,2(3):339-349.DOI:10.1016/j.jcmg.2008.10.017.3569 [30]JIMENEZ-NAVARRO M F,LOPEZ-JIMENEZ F,BARSNESS G,et al.Long-term prognosis of complete percutaneous coronary revascularisation in patients with diabetes with multivessel disease[J].Heart,2015,101(15):1233-1239.DOI:10.1136/heartjnl-2014-307143.3569 [31]张赫男,李曦铭,胡越成,等.冠心病伴2型糖尿病患者PCI预后分析[J].天津医药,2013,41(1):29-32.DOI:10.3969/j.issn.0253-9896.2013.01.009.3569 ZHANG H N,LI X M,HU Y C,et al.Outcomes in patients with type 2 diabetes mellitus undergoing percutaneous coronary intervention[J].Tianjin Medical Journal,2013,41(1):29-32.DOI:10.3969/j.issn.0253-9896.2013.01.009.3570 [32]高海洋,张而立,杨跃进,等.糖尿病及其病程对冠心病患者首次PCI预后的影响[J].中国循环杂志,2013,28(z1):128.3570 GAO H Y,ZHANG E L,YANG Y J,et al.How diabetes and course of diabetes effect the prognosis of CHD patients after fist PCI[J].Chinese Circulation Journal,2013,28(z1):128.3570 [33]NEDKOFF L,KNUIMAN M,HUNG J,et al.Comparative trends in the incidence of hospitalized myocardial infarction and coronary heart disease in adults with and without diabetes mellitus in Western Australia from 1998 to 2010[J].Circ Cardiovasc Qual Outcomes,2014,7(5):708-717.DOI:10.1161/CIRCOUTCOMES.114.000952.3570 [34]吴蕊,杨志明.冠心病介入治疗后再狭窄危险因素的Meta分析[J].中西医结合心脑血管病杂志,2009,7(4):477-478.DOI:10.3969/j.issn.1672-1349.2009.04.046.3570 WU R,YANG Z M.Risk factors of coronary heart disease in correlation with restenosis after transluminal coronary angioplasty and stenting:a meta-analysis[J].Chinese Journal of Integrative Medicine on Cardio/Cerebrovascular Disease,2009,7(4):477-478.DOI:10.3969/j.issn.1672-1349.2009.04.046.3570 [35]GO A S,MOZAFFARIAN D,ROGER V L,et al.Executive summary:heart disease and stroke statistics-2013 update:a report from the American Heart Association[J].Circulation,2013,127(1):143-152.DOI:10.1161/CIR.0b013e318282ab8f.3570 [36]Centers for Disease Control and Prevention(US),National Center for Chronic Disease Prevention and Health Promotion(US),Office on Smoking and Health(US).How tobacco smoke causes disease:the biology and behavioral basis for smoking-attributable disease:a report of the surgeon general[M].Atlanta:Centers for Disease Control and Prevention(US),2010.3570 [37]PAN A,WANG Y,TALAEI M,et al.Relation of smoking with total mortality and cardiovascular events among patients with diabetes mellitus:a meta-analysis and systematic review[J].Circulation,2015,132(19):1795-1804.DOI:10.1161/CIRCULATIONAHA.115.017926.3570 [38]SMITH S C Jr,BENJAMIN E J,BONOW R O,et al.AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease:2011 update:a guideline from the American Heart Association and American College of Cardiology Foundation[J].J Am Coll Cardiol,2011,58(23):2432-2446.DOI:10.1016/j.jacc.2011.10.824.3570 [39]李丹.冠心病二级预防的抗血小板治疗[J].心血管病学进展,2015,36(2):187-191.DOI:10.3969/j.issn.1004-3934.2015.02.017.3570 LI D.Antiplatelet therapy for secondary prevention of coronary artery disease[J].Advances in Cardiovascular Diseases,2015,36(2):187-191.DOI:10.3969/j.issn.1004-3934.2015.02.017.3570 [40]LEMESLE G,LAMBLIN N,MEURICE T,et al.Dual antiplatelet therapy in patients with stable coronary artery disease in modern practice:prevalence,correlates,and impact on prognosis(from the Suivi d'une cohorte de patients COROnariens stables en region NORd-Pas-de-Calais study)[J].Am Heart J,2014,168(4):479-486.DOI:10.1016/j.ahj.2014.06.012.3570 [41]GO A S,CHERTOW G M,FAN D,et al.Chronic kidney disease and the risks of death,cardiovascular events,and hospitalization[J].N Engl J Med,2004,351(13):1296-1305.DOI:10.1056/NEJMoa041031.3570 [42]NAKAMURA K,OKAMURA T,HAYAKAWA T,et al.Chronic kidney disease is a risk factor for cardiovascular death in a community-based population in Japan:NIPPON DATA90[J].Circ J,2006,70(8):954-959.3570 [43]ATHYROS V G,MIKHAILIDIS D P,LIBEROPOULOS E N,et al.Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome:a subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) Study[J].Nephrol Dial Transplant,2007,22(1):118-127.DOI:10.1093/ndt/gfl538.3570 [44]PUN P H,SMARZ T R,HONEYCUTT E F,et al.Chronic kidney disease is associated with increased risk of sudden cardiac death among patients with coronary artery disease[J].Kidney Int,2009,76(6):652-658.DOI:10.1038/ki.2009.219.3570 [45]GO A S,BANSAL N,CHANDRA M,et al.Chronic kidney disease and risk for presenting with acute myocardial infarction versus stable exertional angina in adults with coronary heart disease[J].J Am Coll Cardiol,2011,58(15):1600-1607.DOI:10.1016/j.jacc.2011.07.010.3570 [46]张君毅,宋延彬,胡涛,等.冠心病患者肾功能减退与冠状动脉病变严重程度的相关性研究[J].中国临床医师杂志(电子版),2013,7(7):2904-2908.DOI:10.3877/cma.j.issn.1674-0785.2013.07.036.3570 ZHANG J Y,SONG Y B,HU T,et al.Association of renal dysfunction with severity of coronary artery lesion in patients with coronary heart disease[J].Chinese Journal of Clinicians(Electronic Edition),2013,7(7):2904-2908.DOI:10.3877/cma.j.issn.1674-0785.2013.07.036.3570 [47]HEBERT S A,MOLONY D A.ACP Journal Club:the CKD-EPI equation for eGFR predicted adverse outcomes after PCI better than other equations[J].Ann Intern Med,2015,163(10):Jc12.DOI:10.7326/ACPJC-2015-163-10-012.3570 |
[1] | ZHOU Qibao, LUO Xiao, CHEN Ling, CAO Junda, LI Juxiang, XU Jinsong, SU Hai. Clinical Study on the Diagnostic Value of Circadian Variability of Systolic Blood Pressure Combined with SDNN in Coronary Heart Disease [J]. Chinese General Practice, 2025, 28(30): 3760-3765. |
[2] | WU Wenjun, WEI Jingjing, LI Xue, REN Hongjie, YU Rui, PENG Guangcao, ZHU Mingjun. Regularity of Prescriptions for Coronary Heart Disease with Hypertension Based on Latent Structure and Association Rules [J]. Chinese General Practice, 2025, 28(30): 3787-3795. |
[3] | XU Yanpeng, HUANG Pe, ZHANG Pingping, LUO Yan, SHI Xiaoqi, WU Liusong, CHEN Yan, HE Zhixu. Expression of β-Adrenergic Receptors in Acute T-cell Lymphoblastic Leukemia and Its Clinical Significance [J]. Chinese General Practice, 2025, 28(27): 3391-3398. |
[4] | HU Jieman, TAN Feixiang, YUAN Anxin, CHEN Shiyu, TANG Chulei, YIN Yueheng, BA Lei, XU Qin. Analysis of the Trajectory of Postoperative Frailty and Influencing Factors in Patients with Colorectal Cancer [J]. Chinese General Practice, 2025, 28(26): 3276-3282. |
[5] | CHOU Xintong, PENG Hanyu, MA Hui, ZHANG Zhen, SU Xian, QIU Hongyan. Maternal Preferences in Contraceptive Decision-making: an Analysis of Influencing Factors [J]. Chinese General Practice, 2025, 28(26): 3294-3299. |
[6] | WEI Jiaohua, PENG Huiru, PENG Jianye, TAN Wenting, HUANG Jine, FANG Li. Expression of the Serum MOTS-c and Its Correlation with Atrial Remodeling in Patients with Atrial Fibrillation [J]. Chinese General Practice, 2025, 28(26): 3271-3276. |
[7] | YU Zizi, LIU Duli, LI Ximin, RUAN Chunyi, YIN Xiangyang, CAI Le. Analysis of the Prevalence and Self-management of Hypertension and Its Influencing Factors in Rural [J]. Chinese General Practice, 2025, 28(25): 3137-3143. |
[8] | FAN Boyang, ZHANG Yu, SUN Wenning, ZHANG Huifang, WANG Yingjie, ZHANG Ao, ZHAO Yang, WANG Haipeng. Study of Behavioral Intention and Influencing Factors of Integrated Medical and Preventive Care Provided by Grassroots Doctors for Patients with Chronic Diseases [J]. Chinese General Practice, 2025, 28(25): 3144-3150. |
[9] | YANG Chen, CHEN Tong, ZHANG Lifang, ZHANG Hongxu, LI Pengfei, ZHANG Xuejuan. Prognostic Impact of Dapagliflozin in Elderly Breast Cancer Survivors with Heart Failure with Preserved Ejection Fraction and Type 2 Diabetes [J]. Chinese General Practice, 2025, 28(24): 3053-3058. |
[10] | WANG Rupeng, NAN Jing, HU Yiran, YANG Shenghua, JIN Zening. Predictive Value of the Triglyceride-Glucose Body Mass Index for Slow Flow/No-reflow Phenomenon in Patients with Type 2 Diabetes Mellitus and Acute Myocardial Infarction Undergoing Emergency Percutaneous Coronary Intervention [J]. Chinese General Practice, 2025, 28(24): 2985-2992. |
[11] | WU Yue, WANG Xuetong, KE Bilian. Evaluation of Vision-related Quality of Life in Myopic Macular Degeneration Patients with Low Vision and Associated Factors [J]. Chinese General Practice, 2025, 28(23): 2908-2914. |
[12] | DING Zijun, ZHOU Nannan, LUO Xing, LUO Jieyu, HAO Wenjuan, ZHANG Chunjiang, JIN Xin, ZHAO Dan. Cognitive Impairment in Patients on Maintenance Hemodialysis and Its Influencing Factors: a Multicenter Cross-sectional Study [J]. Chinese General Practice, 2025, 28(23): 2885-2893. |
[13] | CHEN Fei, WANG Jinying, YU Haibo, LI Xin, ZHANG Jiajia, SHEN Man, ZHAN Xiaokai, TANG Ran, FAN Sibin, ZHAO Fengyi, ZHANG Tianyu, HUANG Zhongxia. Significance of Elevated Urinary NGAL, TIM-1, VCAM-1 and Activin A in Patients with New Diagnosed Multiple Myeloma [J]. Chinese General Practice, 2025, 28(22): 2740-2749. |
[14] | YANG Ji, ZHANG Yao, ZHAO Yingqiang, ZHANG Qiuyue. Evaluation of the Effectiveness of TCM Three-level Prevention and Control Model in the Management of Patients with Coronary Heart Disease and Stroke: a Single-center, Prospective Cohort Study [J]. Chinese General Practice, 2025, 28(22): 2750-2761. |
[15] | WEI Xiaoxia, CHEN Nuo, WANG Juanjuan, ZHU Jingfen. The Effects of Depression and Anxiety on Smoking Behavior among Vocational School Students [J]. Chinese General Practice, 2025, 28(22): 2826-2832. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||